DE69109933D1 - Verwendung von Mizoribin zur Behandlung oder Vorbeugung der Multiplen Sklerose. - Google Patents
Verwendung von Mizoribin zur Behandlung oder Vorbeugung der Multiplen Sklerose.Info
- Publication number
- DE69109933D1 DE69109933D1 DE69109933T DE69109933T DE69109933D1 DE 69109933 D1 DE69109933 D1 DE 69109933D1 DE 69109933 T DE69109933 T DE 69109933T DE 69109933 T DE69109933 T DE 69109933T DE 69109933 D1 DE69109933 D1 DE 69109933D1
- Authority
- DE
- Germany
- Prior art keywords
- multiple sclerosis
- mizoribin
- treat
- prevent multiple
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 3
- HZQDCMWJEBCWBR-UUOKFMHZSA-N Mizoribine Chemical compound OC1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 HZQDCMWJEBCWBR-UUOKFMHZSA-N 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 230000037396 body weight Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 229950000844 mizoribine Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2127529A JPH0649650B2 (ja) | 1990-05-17 | 1990-05-17 | ４―カルバモイル―１―β―Ｄ―リボフラノシル―イミダゾリウム―５―オレイトを有効成分とする用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69109933D1 true DE69109933D1 (de) | 1995-06-29 |
| DE69109933T2 DE69109933T2 (de) | 1996-02-08 |
Family
ID=14962276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69109933T Expired - Fee Related DE69109933T2 (de) | 1990-05-17 | 1991-05-16 | Verwendung von Mizoribin zur Behandlung oder Vorbeugung der Multiplen Sklerose. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5472947A (de) |
| EP (1) | EP0457336B1 (de) |
| JP (1) | JPH0649650B2 (de) |
| AT (1) | ATE122889T1 (de) |
| AU (1) | AU631989B2 (de) |
| CA (1) | CA2042752A1 (de) |
| DE (1) | DE69109933T2 (de) |
| DK (1) | DK0457336T3 (de) |
| NZ (1) | NZ238163A (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06116151A (ja) * | 1991-08-06 | 1994-04-26 | Asahi Chem Ind Co Ltd | 増殖性皮膚疾患治療用組成物 |
| AU2003261354A1 (en) * | 2002-08-02 | 2004-02-23 | The Regents Of The University Of California | New uses for inhibitors of inosine monophosphate dehydrogenase |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4912720B2 (de) * | 1971-11-15 | 1974-03-26 | ||
| US3888843A (en) * | 1973-06-12 | 1975-06-10 | Toyo Jozo Kk | 4-carbamoyl-1-' -d-ribofuranosylimidazolium-5-olate |
| JPS5652038B2 (de) * | 1974-03-09 | 1981-12-09 | ||
| JPS5647196B2 (de) * | 1974-03-09 | 1981-11-07 | ||
| JPS511693A (en) * | 1974-06-21 | 1976-01-08 | Toyo Jozo Kk | 44 karubamoiru 11 beetaa dd ribofuranoshiiru imidazoriumu 55 oreitonoseizoho |
| US3960836A (en) * | 1974-07-22 | 1976-06-01 | Eli Lilly And Company | Acylated derivatives of pyrazofurin and process for their preparation |
| JPS57156418A (en) * | 1981-03-19 | 1982-09-27 | Sumitomo Chem Co Ltd | Carcinostatic |
| JPS60142998A (ja) * | 1983-12-28 | 1985-07-29 | Toyo Jozo Co Ltd | ５’−デオキシブレデイニンおよびその製造法 |
| JPS60193997A (ja) * | 1984-03-14 | 1985-10-02 | Sumitomo Chem Co Ltd | 新規シアノイミダゾ−ルリボヌクレオシド誘導体およびその製造法 |
-
1990
- 1990-05-17 JP JP2127529A patent/JPH0649650B2/ja not_active Expired - Lifetime
-
1991
- 1991-05-15 AU AU77034/91A patent/AU631989B2/en not_active Ceased
- 1991-05-16 AT AT91107985T patent/ATE122889T1/de not_active IP Right Cessation
- 1991-05-16 EP EP91107985A patent/EP0457336B1/de not_active Expired - Lifetime
- 1991-05-16 DK DK91107985.3T patent/DK0457336T3/da active
- 1991-05-16 NZ NZ238163A patent/NZ238163A/en unknown
- 1991-05-16 DE DE69109933T patent/DE69109933T2/de not_active Expired - Fee Related
- 1991-05-16 CA CA002042752A patent/CA2042752A1/en not_active Abandoned
-
1994
- 1994-07-28 US US08/281,613 patent/US5472947A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0457336A2 (de) | 1991-11-21 |
| AU631989B2 (en) | 1992-12-10 |
| JPH0421632A (ja) | 1992-01-24 |
| JPH0649650B2 (ja) | 1994-06-29 |
| DK0457336T3 (da) | 1995-08-07 |
| US5472947A (en) | 1995-12-05 |
| CA2042752A1 (en) | 1991-11-18 |
| ATE122889T1 (de) | 1995-06-15 |
| AU7703491A (en) | 1991-11-21 |
| EP0457336A3 (en) | 1992-03-04 |
| NZ238163A (en) | 1997-06-24 |
| DE69109933T2 (de) | 1996-02-08 |
| EP0457336B1 (de) | 1995-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| PL309398A1 (en) | Interferon containing therapeutic composition | |
| DE69230046T2 (de) | 2-Bromomelatonin zur Behandlung von Schlafstörungen | |
| CA2130275A1 (en) | Use of Substituted Adenine Derivatives for Treating Multiple Sclerosis | |
| DE69521536T2 (de) | Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten | |
| IL89031A0 (en) | Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation | |
| SG48733A1 (en) | Use of il-10 to prevent or treat insulin-dependent diabetes mellitus | |
| ATE161725T1 (de) | Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina | |
| DE69109933D1 (de) | Verwendung von Mizoribin zur Behandlung oder Vorbeugung der Multiplen Sklerose. | |
| IL126795A0 (en) | Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders | |
| EP0286802A3 (de) | Verwendung von Ofloxacin zur lokalen Behandlung oder Prophylaxe von Beschwerden der Wurzelhaut der Zähne | |
| DE68910010D1 (de) | Verwendung von Dapiprazol zur Herstellung eines Arzneimittels zur Verhinderung des Toleranzentwicklung bei der analgetischen Behandlung mit Morphin. | |
| ATE168690T1 (de) | Indolderivate, ihre salze und sie enthaltende arzneimittel zur behandlung von herzkrankheiten | |
| EP0353910A3 (en) | Human interferon-gamma, process for preparing said human interferon-gamma, and its use | |
| IL98200A0 (en) | Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide | |
| ATE133070T1 (de) | Verwendung von 3-oxygermylpropionsäure zur behandlung des erkältungssyndroms | |
| ATE316373T1 (de) | Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn | |
| ATE81466T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. | |
| KR890007737A (ko) | 진토작용을 하는 약제 | |
| KR940003550A (ko) | 노인성 치매 예방 및 치료방법 | |
| RU94002713A (ru) | Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |